Literature DB >> 23305744

Hope abandoned: memantine therapy in frontotemporal dementia.

John R Hodges1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23305744     DOI： 10.1016/S1474-4422(13)70001-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

1.  Neurodegenerative disease: Frontotemporal dementia--time to target inflammation?

Authors:  Olivier Piguet
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

2.  Efficacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: A six-month, open-label, self-controlled clinical trial.

Authors:  Pan Li; Wei Quan; Yu-Ying Zhou; Yan Wang; Hui-Hong Zhang; Shuai Liu
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

3.  Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database.

Authors:  Joseph E Gaugler; Haya Ascher-Svanum; David L Roth; Tolulope Fafowora; Andrew Siderowf; Thomas G Beach
Journal:  BMC Geriatr       Date:  2013-12-19       Impact factor: 3.921

Review 4.  Enhancement of carer skills and patient function in the non-pharmacological management of frontotemporal dementia (FTD): A call for randomised controlled studies.

Authors:  Claire M O'Connor; Lindy Clemson; Thaís Bento Lima da Silva; Olivier Piguet; John R Hodges; Eneida Mioshi
Journal:  Dement Neuropsychol       Date:  2013 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.